[ERCC and Ki67 in bronchogenic carcinoma: up to date]
Related Experiment Video
Updated: Oct 23, 2026
11:34
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Recenti Progressi in Medicina
|October 13, 2011
Abstract:
On the bases of the more recent literature, the authors come out in favour of the topical prognostic value of Ki-67 in special instances as "supplementary test" rather than Excision Repair Crossing Complementation group 1 expression.
